Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.12. | Vext Science Inc: Vext Science shareholders approve all matters at AGM | 2 | Stockwatch | ||
13.12. | VEXT Science, Inc.: Vext Announces Voting Results of Annual General Meeting | 673 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 13, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("VEXT" or the "Company") a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
12.12. | Vext Science Inc: Vext receives provisional Portsmouth dispensary licence | 4 | Stockwatch | ||
VEXT SCIENCE Aktie jetzt für 0€ handeln | |||||
11.12. | VEXT Science, Inc.: Vext Secures Fifth Ohio Dispensary Location, Strengthening Retail Footprint | 432 | Newsfile | Vext's fifth Ohio dispensary, located in Portsmouth, is expected to commence operations in Q2 or Q3 of 2025, pending regulatory approvals.The Company expects to reach the state license cap of eight... ► Artikel lesen | |
04.12. | Vext Science Inc: Vext Science hires Zuanic for extended services | 2 | Stockwatch | ||
03.12. | VEXT Science, Inc.: Vext Extends Engagement with Zuanic & Associates | 373 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 3, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
25.11. | Vext Science Inc: Vext Science files, mails circular for Dec. 13 AGM | 3 | Stockwatch | ||
25.11. | VEXT Science, Inc.: Vext Provides Update on Annual General Meeting | 207 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 25, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
21.11. | Vext Science reports Q3 results | 2 | Seeking Alpha | ||
21.11. | VEXT Science, Inc.: Vext Reports Solid Financial Results for Q3 2024 | 484 | Newsfile | Generated $9.0 million in revenue and Adjusted EBITDA1 of $2.9 million, driven by early growth from rollout of adult-use sales in Ohio, market share gains in Arizona and disciplined cost control.Well... ► Artikel lesen | |
07.11. | Vext Science Inc: Vext Science to release Q3 2024 results Nov. 21 | 4 | Stockwatch | ||
07.11. | VEXT Science, Inc.: Vext to Announce Financial Results for Q3 2024 on November 21, 2024 | 251 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 7, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
23.09. | Vext Science Inc: Vext Science hires PartnerCap for IR services | 2 | Stockwatch | ||
23.09. | VEXT Science, Inc.: Vext Engages PartnerCap Securities, LLC | 562 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - September 23, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations... ► Artikel lesen | |
21.08. | Vext Science Inc: Vext Science omits Q2 net P&L in NR, talks revenue | 2 | Stockwatch | ||
20.08. | Vext Science reports Q2 results | 2 | Seeking Alpha | ||
20.08. | VEXT Science, Inc.: Vext Announces Financial Results for Q2 2024 | 371 | Newsfile | Revenue of $8.4 million; Adjusted EBITDA1 of $1.1 million.With one of the largest footprints in Ohio amongst publicly traded peers, Vext is well-positioned to grow revenue and cash flow from operations... ► Artikel lesen | |
09.08. | Vext Science Inc: Vext Science to release Q2 2024 results Aug. 20 | 2 | Stockwatch | ||
09.08. | VEXT Science, Inc.: Vext to Announce Financial Results for Q2 2024 on August 20, 2024 | 670 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - August 9, 2024) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in... ► Artikel lesen | |
02.08. | Vext Science Inc: Vext Science receives Ohio okay for adult use cannabis | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 4,100 | -0,73 % | Aurora Cannabis Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
CANOPY GROWTH | 2,735 | -1,26 % | Ausverkauf und dann Comeback?: Darum sind Tilray, Canopy & Co. potenzielle Highflyer in 2025. Und darum nicht | © Foto: adobe.stock.comDas Jahresende bringt für den Cannabis-Sektor noch einmal Turbulenzen mit sich. Das Jahr endet, wie es verlief; könnte man salopp formulieren. Zudem dürfte Tilray, Canopy & Co.... ► Artikel lesen | |
TILRAY BRANDS | 1,366 | -0,58 % | Tilray (NASDAQ:TLRY) Shares Down 1.4% - Here's What Happened | ||
INNOCAN PHARMA | 0,128 | +4,51 % | Innocan Pharma Corporation: Innocan Pharma Announces Private Placement of Units | HERZLIYA, Israel and CALGARY, AB, Dec. 19, 2024 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,146 | +20,25 % | XFRA 2TP0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
CRONOS GROUP | 1,949 | +1,19 % | Cronos Group Inc.: Cronos Group Reports 2024 Third Quarter Results | Net revenue in Q3 2024 increased by 38% year-over-year to $34.3 million Spinach® Becomes the Number One Cannabis Brand in Canada1 Industry-leading balance sheet with $862 million in cash and cash... ► Artikel lesen | |
SYNBIOTIC | 4,360 | -0,46 % | EQS-News: SYNBIOTIC SE: Richtungsweisende Dekontamination: SYNBIOTIC und GOC NEXUS setzen Goldstandard für Cannabis | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Richtungsweisende Dekontamination: SYNBIOTIC und GOC NEXUS setzen Goldstandard für Cannabis
18.12.2024... ► Artikel lesen | |
TRANSCANNA | 0,017 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
DIGICANN VENTURES | 0,004 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN) | le 30 septembre/September 2024
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | -33,33 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
ORGANIGRAM | 1,470 | -2,91 % | Organigram Reports Fourth Quarter and Fiscal 2024 Results | TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer ("LP") of cannabis, announced its results for the fourth... ► Artikel lesen | |
CRESCO LABS | 0,821 | -2,61 % | Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results | Record quarterly operating cash flow of $49 million and year to date operating cashflow of $103 million, an increase of 66% from the prior year period
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF)... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 7,580 | -1,30 % | Multi-Bagger entdeckt!: Der europäische Cannabissektor wird in den nächsten Jahren auf 24 Mrd. $ explodieren - diese Aktie profitiert! | ||
SNDL | 1,765 | -1,01 % | SNDL Inc.: SNDL Reports Third Quarter 2024 Financial and Operational Results | The Company reports record Gross Margin and positive Cash Flow and Free Cash Flow
CALGARY, AB, Nov. 5, 2024 /CNW/ - SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,002 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen |